Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors(385 views) Pedicini P, Caivano R, Jereczek-Fossa BA, Strigari L, Vischioni B, Alterio D, Cremonesi M, Botta F, Nappi A, Improta G, Storto G, Benassi M, Orecchia R
Theor Biol Med Model (ISSN: 1742-4682), 2012 Jun 19; 9(1): 23-23.
I.R.C.C.S., C.R.O.B Regional Cancer Hospital, Rionero in Vulture, Italy
U.O. of Radiotherapy, I.E.O. European Institute of Oncology, Milan, Italy
University of Milan, Milan, Italy
Laboratory of Medical Physics and Expert Systems, Regina Elena National Cancer Institute, Rome, Italy
U.O. of Radiobiology, C.N.A.O, Pavia, Italy
Service of Medical Physics, I.E.O. European Institute of Oncology, Milan, Italy
Department of Radiation Oncology, IRCCS CROB, 1 Padre Pio Street, 85028, Rionero in Vulture, PZ, Italy
I. R. C. C. S., C. R. O. B Regional Cancer Hospital, Rionero in Vulture, Italy
U. O. of Radiotherapy, I. E. O. European Institute of Oncology, Milan, Italy
U. O. of Radiobiology, C. N. A. O, Pavia, Italy
References: Lammering, G., Molecular predictor and promising target: Will EGFr now become a star in radiotherapy? (2005) Radioth Oncol, 74, pp. 89-91. , 10.1016/j.radonc.2005.01.00
Harari, P., Huang, S.M., Modulation of molecular targets to enhance radiation (2000) Clin Cancer Res, 6, pp. 323-335. , 10690506
Baumann, M., Krause, M., Dikomey, E., Dittmann, K., Dörr, W., Kasten Pisula, U., Rodemann, H.P., EGFr targeted anticancer drugs in radiotherapy: Preclinical evaluation of mechanisms (2007) Radioth Oncol, 83, pp. 238-248. , 10.1016/j.radonc.2007.04.006
Morgan, M.A., Parsels, L.A., Kollar, L.E., Normolle, D.P., Maybaum, J., Lawrence, T.S., The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer (2008) Clin Cancer Res, 14, pp. 5142-5149. , 10.1158/1078-0432.CCR-07-4072 18698032
Fowler, J.F., The linear quadratic formula and progress in fractionated radiotherapy (1989) Brit J Rad, 62, pp. 679-694. , 10.1259/0007-1285-62-740-679
Niemierko, A., Goitein, M., Implementation of model for estimating tumour control probability for an inhomogeneously irradiated tumour (1993) Radioth Oncol, 29, pp. 140-147. , 10.1016/0167-8140(93)90239-5
Zaider, M., Hanin, L., Biologically equivalent dose and long term survival time in radiation treatments (2007) Phys Med Biol, 52, pp. 6355-6362. , 10.1088/0031-9155/52/20/017 17921589
Dubray, B.M., Thames, H.D., The clinical significance of ratios of radiobiological parameters (1996) Int J Radiat Oncol Biol Phys, 35, pp. 1099-1111. , 10.1016/0360-3016(96)00255-6 8751420
Barendsen, G.W., Dose fractionation, dose rate and isoeffect relationships for normal tissue responses (1982) Int J Radiat Oncol Biol Phys, 8, pp. 779-790
Hendry, J.H., Bentzen, S.M., Dale, R.G., Fowler, J.F., Wheldon, T.E., Jones, B., Munro, A.J., Robertson, A.G., A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy (1996) Clin Oncol, 8, pp. 297-307. , 10.1016/S0936-6555(05)80715-0
Zagars, G.K., Schultheiss, T.E., Peters, L.J., Inter tumour heterogeneity and radiation dose control curves (1987) Radioth Oncol, 8, pp. 353-362. , 10.1016/S0167-8140(87)80186-X
Eriksen, J.G., Steiniche, T., Overgaard, J., Head, D., The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma (2005) Acta Oncol, 44, pp. 50-58. , 10.1080/02841860510007396 15848906 Cancer Study Group
Bengt, K.L., Brahme, A., The radiation response of heterogeneous tumours (2007) Phys Med, 23, pp. 91-99. , 10.1016/j.ejmp.2007.08.001 17950648
Webb, S., Nahum, A.E., A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distribution of dose and clonogenic cell density (1993) Phys Med Biol, 38, pp. 653-666. , 10.1088/0031-9155/38/6/001 8346278
Ang, K.K., Berkey, B.A., Tu, X., Zhang, H.Z., Katz, R., Hammond, E.H., Fu, K.K., Milas, L., Impact of Epidermal Growth Factor Receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma (2002) Cancer Res, 62, pp. 7350-7356. , 12499279
Dittmann, K., Mayer, C., Rodemann, H.P., Inhibition of radiation induced EGFr nuclear import by C225 (Cetuximab) suppresses DNA PK activity (2005) Radioth Oncol, 76, pp. 157-161. , 10.1016/j.radonc.2005.06.022
Akashi, Y., Okamoto, I., Iwasa, T., Yoshida, T., Hatashita, Y., Yamada, Y., Satoh, T., Nakagawa, K., Enhancement of the antitumour activity of ionising radiation by nimotuzumab, a humanised monoclonal antibody to the epidermal growth factor receptor, in non-small cell lung cancer cell lines of differing epidermal growth factor receptor status (2008) Br J Cancer, 98, pp. 749-755. , 10.1038/sj.bjc.6604222 18253126
Bonner, J.A., Maihle, N.J., Folven, B.R., Christianson, T.J., Spain, K., The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities (1994) Int J Radiat Oncol Biol Phys, 29, pp. 243-247. , 10.1016/0360-3016(94)90269-0 8195014
Barendsen, G.W., Differences in radiosensitivity among cells in culture and in experimental tumours: Significance for the effectiveness of human cancer therapy (1987) Radioth Oncol, 8, pp. 285-300. , 10.1016/S0167-8140(87)80178-0
Fracasso, P.M., Iii, B.H., Arquette, M.A., Govindan, R., Gao, F., Wright, L.P., Goodner, S.A., Garrett, C.R., A Phase 1 Escalating Single Dose and Weekly Fixed Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing (2007) Clin Cancer Res, 13, pp. 986-993. , 10.1158/1078-0432.CCR-06-1542 17289894
Joiner, M.C., Van Der Kogel, A.J., The linear-quadratic approach to fractionation and calculation of isoeffect relationships (1997) Basic Clinical Radiobiology, pp. 107-122. , London: Arnold Steel GG
Barendsen, G.W., RBE as a function of dose for effects on tissues and tumours assessed by the linear quadratic model (2000) Int J Radiat Oncol Biol Phys, 46, pp. 684-685. , 10701750
Carlson, D.J., Stewart, R.D., Li, X.A., Jennings, K., Wang, J.Z., Guerrero, M., Comparison of in vitro and in vivo α/β ratios for prostate cancer (2004) Phys Med Biol, 49, pp. 4477-4491. , 10.1088/0031-9155/49/19/003 15552412
Begg, A.C., Vens, C., Genetic manipulation of radiosensitivity (2001) Int J Radiat Oncol Biol Phys, 49, pp. 367-371. , 10.1016/S0360-3016(00)01497-8 11173129
Brown, J.M., Therapeutic targets in radiotherapy (2001) Int J Radiat Oncol Biol Phys, 49, pp. 319-326. , 10.1016/S0360-3016(00)01482-6 11173124
Strigari, L., D'Andrea, M., Abate, A., Benassi, M., A heterogeneous dose distribution in simultaneous integrated boost: The role of the clonogenic cell density on the tumour control probability (2008) Phys Med Biol, 53, pp. 5257-5273. , 10.1088/0031-9155/53/19/001 18758004
Roberts, S.A., Hendry, J.H., A realistic closed-form radiobiological model of clinical tumour-control data incorporating intertumour heterogeneity (1998) Int J Radiat Oncol Biol Phys, 41, pp. 689-699. , 10.1016/S0360-3016(98)00100-X 9635721
Thariat, J., Milas, L., Ang, K.K., Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of the head and neck cancer (2007) Int J Radiat Oncol Biol Phys, 69, pp. 974-984. , 10.1016/j.ijrobp.2007.06.076 17967298
Suwinski, R., Jaworska, M., Nikiel, B., Grzegorz, W., Bankowska-Wwozniak, M., Wojciech, M., Krysztof, S., Dariusz, L., Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: Data from a randomized clinical trial (2010) Int J Radiat Oncol Biol Phys, 77, pp. 438-446. , 10.1016/j.ijrobp.2009.05.021 19733016
Chung, C.H., Zhang, Q., Hammond, E.M., Trotti III, A.M., Wang, H., Spencer, S., Zhang, H.Z., Ang, K.K., Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma (2010) Int J Radiat Oncol Biol Phys, 81, pp. 331-338. , 20732768
Bentzen, S.M., Atasoy, B.M., Daley, F.M., Dische, S., Richman, P.I., Saunders, M.I., Trott, K.R., Wilson, G.D., Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial (2005) J Clin Oncol, 23, pp. 5560-5567. , 10.1200/JCO.2005.06.411 16110017
Smid, E.J., Stoter, T.R., Bloemena, E., Lafleur, M.V., Leemans, C.R., Van Der Waal, I., Slotman, B.J., Langendijk, J.A., The importance of immunohistochemical expression of EGFr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy (2006) Int J Radiat Oncol Biol Phys, 65, pp. 1323-1329. , 10.1016/j.ijrobp.2006.03.011 16750322
Morgan, M. A., Parsels, L. A., Kollar, L. E., Normolle, D. P., Maybaum, J., Lawrence, T. S., The combination of epidermal growth factor receptor inhibitors with gemcitabine and radiation in pancreatic cancer (2008) Clin Cancer Res, 14, pp. 5142-5149. , 10. 1158/1078-0432. CCR-07-4072 18698032
Fowler, J. F., The linear quadratic formula and progress in fractionated radiotherapy (1989) Brit J Rad, 62, pp. 679-694. , 10. 1259/0007-1285-62-740-679
Dubray, B. M., Thames, H. D., The clinical significance of ratios of radiobiological parameters (1996) Int J Radiat Oncol Biol Phys, 35, pp. 1099-1111. , 10. 1016/0360-3016 (96) 00255-6 8751420
Barendsen, G. W., Dose fractionation, dose rate and isoeffect relationships for normal tissue responses (1982) Int J Radiat Oncol Biol Phys, 8, pp. 779-790
Hendry, J. H., Bentzen, S. M., Dale, R. G., Fowler, J. F., Wheldon, T. E., Jones, B., Munro, A. J., Robertson, A. G., A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapy (1996) Clin Oncol, 8, pp. 297-307. , 10. 1016/S0936-6555 (05) 80715-0
Zagars, G. K., Schultheiss, T. E., Peters, L. J., Inter tumour heterogeneity and radiation dose control curves (1987) Radioth Oncol, 8, pp. 353-362. , 10. 1016/S0167-8140 (87) 80186-X
Eriksen, J. G., Steiniche, T., Overgaard, J., Head, D., The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma (2005) Acta Oncol, 44, pp. 50-58. , 10. 1080/02841860510007396 15848906 Cancer Study Group
Bengt, K. L., Brahme, A., The radiation response of heterogeneous tumours (2007) Phys Med, 23, pp. 91-99. , 10. 1016/j. ejmp. 2007. 08. 001 17950648
Ang, K. K., Berkey, B. A., Tu, X., Zhang, H. Z., Katz, R., Hammond, E. H., Fu, K. K., Milas, L., Impact of Epidermal Growth Factor Receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma (2002) Cancer Res, 62, pp. 7350-7356. , 12499279
Bonner, J. A., Maihle, N. J., Folven, B. R., Christianson, T. J., Spain, K., The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities (1994) Int J Radiat Oncol Biol Phys, 29, pp. 243-247. , 10. 1016/0360-3016 (94) 90269-0 8195014
Fracasso, P. M., Iii, B. H., Arquette, M. A., Govindan, R., Gao, F., Wright, L. P., Goodner, S. A., Garrett, C. R., A Phase 1 Escalating Single Dose and Weekly Fixed Dose Study of Cetuximab: Pharmacokinetic and Pharmacodynamic Rationale for Dosing (2007) Clin Cancer Res, 13, pp. 986-993. , 10. 1158/1078-0432. CCR-06-1542 17289894
Joiner, M. C., Van Der Kogel, A. J., The linear-quadratic approach to fractionation and calculation of isoeffect relationships (1997) Basic Clinical Radiobiology, pp. 107-122. , London: Arnold Steel GG
Barendsen, G. W., RBE as a function of dose for effects on tissues and tumours assessed by the linear quadratic model (2000) Int J Radiat Oncol Biol Phys, 46, pp. 684-685. , 10701750
Carlson, D. J., Stewart, R. D., Li, X. A., Jennings, K., Wang, J. Z., Guerrero, M., Comparison of in vitro and in vivo / ratios for prostate cancer (2004) Phys Med Biol, 49, pp. 4477-4491. , 10. 1088/0031-9155/49/19/003 15552412
Begg, A. C., Vens, C., Genetic manipulation of radiosensitivity (2001) Int J Radiat Oncol Biol Phys, 49, pp. 367-371. , 10. 1016/S0360-3016 (00) 01497-8 11173129
Brown, J. M., Therapeutic targets in radiotherapy (2001) Int J Radiat Oncol Biol Phys, 49, pp. 319-326. , 10. 1016/S0360-3016 (00) 01482-6 11173124
Roberts, S. A., Hendry, J. H., A realistic closed-form radiobiological model of clinical tumour-control data incorporating intertumour heterogeneity (1998) Int J Radiat Oncol Biol Phys, 41, pp. 689-699. , 10. 1016/S0360-3016 (98) 00100-X 9635721
Chung, C. H., Zhang, Q., Hammond, E. M., Trotti III, A. M., Wang, H., Spencer, S., Zhang, H. Z., Ang, K. K., Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma (2010) Int J Radiat Oncol Biol Phys, 81, pp. 331-338. , 20732768
Bentzen, S. M., Atasoy, B. M., Daley, F. M., Dische, S., Richman, P. I., Saunders, M. I., Trott, K. R., Wilson, G. D., Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial (2005) J Clin Oncol, 23, pp. 5560-5567. , 10. 1200/JCO. 2005. 06. 411 16110017
Smid, E. J., Stoter, T. R., Bloemena, E., Lafleur, M. V., Leemans, C. R., Van Der Waal, I., Slotman, B. J., Langendijk, J. A., The importance of immunohistochemical expression of EGFr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy (2006) Int J Radiat Oncol Biol Phys, 65, pp. 1323-1329. , 10. 1016/j. ijrobp. 2006. 03. 011 16750322
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors
Modelling the correlation between EGFr expression and tumour cell radiosensitivity, and combined treatments of radiation and monoclonal antibody EGFr inhibitors